Vimarsana.com

Latest Breaking News On - Genfit company profile - Page 1 : vimarsana.com

Genfit (EPA:GNFT) Trading Down 0.8%

Shares of Genfit S.A. (EPA:GNFT – Get Free Report) fell 0.8% on Thursday . The company traded as low as €3.19 ($3.39) and last traded at €3.21 ($3.41). 36,724 shares were traded during mid-day trading, The stock had previously closed at €3.24 ($3.44). Genfit Price Performance The business’s fifty day moving average is €3.26 and […]

Genfit-company-profile
Get-free-report
Urea-cycle-disorder
Organic-acidemia-disorder
Blood-ammonia
Genfit-daily
Genfit
Epa-gnft
Gnft
Medical
Stocks

Genfit (EPA:GNFT) Trading Up 1.1%

Genfit (EPA:GNFT) Trading Up 1.1%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Genfit-company-profile
Get-free-report
Urea-cycle-disorder
Organic-acidemia-disorder
Genfit-daily

Genfit (EPA:GNFT) Stock Price Up 1.1%

Genfit (EPA:GNFT) Stock Price Up 1.1%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Genfit-company-profile
Get-free-report
Stock-down
Urea-cycle-disorder
Organic-acidemia-disorder
Genfit-daily

Leerink Partnrs Comments on Genfit S.A.'s FY2026 Earnings (NASDAQ:GNFT)

Genfit S.A. (NASDAQ:GNFT – Free Report) – Research analysts at Leerink Partnrs issued their FY2026 earnings per share (EPS) estimates for Genfit in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith anticipates that the company will post earnings per share of ($0.67) for the year. The consensus estimate for Genfit’s current […]

Leerink-partnrs
Shaughnessy-asset-management
Citadel-advisors
Envestnet-asset-management-inc
Optiver-holding
Genfit-company-profile
Free-report
Asset-management
Get-free-report
Urea-cycle-disorder
Organic-acidemia-disorder
Genfit-daily

Short Interest in Genfit S.A. (OTCMKTS:GNFTF) Grows By 91.2%

Genfit S.A. (OTCMKTS:GNFTF – Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 115,300 shares, an increase of 91.2% from the November 30th total of 60,300 shares. Based on an average daily trading volume, of 300 shares, the days-to-cover ratio […]

Genfit-company-profile
Get-free-report
Urea-cycle-disorder
Organic-acidemia-disorder
Genfit-daily
Genfit
Otcmkts-gnftf
Gnftf
Medical
Stocks
Options

Genfit (NASDAQ:GNFT) Rating Reiterated by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a research report released on Friday morning, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. Genfit Price Performance GNFT stock opened at $3.43 on Friday. Genfit has a 1-year low of $2.89 and a 1-year […]

Genfit-company-profile
Citadel-advisors
Envestnet-asset-management-inc
Shaughnessy-asset-management
O-shaughnessy-asset-management
Optiver-holding
Free-report
Asset-management
Get-free-report
Urea-cycle-disorder
Organic-acidemia-disorder

Genfit S.A. (NASDAQ:GNFT) Sees Large Decrease in Short Interest

Genfit S.A. (NASDAQ:GNFT – Get Free Report) was the target of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 114,300 shares, a drop of 8.1% from the September 15th total of 124,400 shares. Based on an average daily volume of 26,800 shares, the […]

Shaughnessy-asset-management
Citadel-advisors
Genfit-company-profile
Optiver-holding
Envestnet-asset-management-inc
Nasdaq
Get-free-report
Asset-management
Urea-cycle-disorder
Organic-acidemia-disorder
Genfit-daily

Equities Analysts Offer Predictions for Genfit S.A.'s FY2024 Earnings (NASDAQ:GNFT)

Equities Analysts Offer Predictions for Genfit S.A.'s FY2024 Earnings (NASDAQ:GNFT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs
Genfit-company-profile
Optiver-holding
Envestnet-asset-management-inc
Citadel-advisors
Shaughnessy-asset-management
Free-report
Asset-management
Get-free-report
Urea-cycle-disorder
Organic-acidemia-disorder
Genfit-daily

Genfit S.A. (NASDAQ:GNFT) Sees Large Drop in Short Interest

Genfit S.A. (NASDAQ:GNFT – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 104,000 shares, a decrease of 10.2% from the August 15th total of 115,800 shares. Currently, 0.2% of the shares of the company are short […]

Shaughnessy-asset-management
Optiver-holding
Genfit-company-profile
Citadel-advisors
Envestnet-asset-management-inc
Get-free-report
Asset-management
Urea-cycle-disorder
Organic-acidemia-disorder
Genfit-daily
Genfit

Genfit (GNFTF) versus Its Competitors Head-To-Head Comparison

Genfit (OTCMKTS:GNFTF – Free Report) is one of 374 public companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Genfit to related businesses based on the strength of its institutional ownership, valuation, analyst recommendations, risk, earnings, dividends and profitability. Valuation & Earnings This table compares Genfit and its […]

France
Genoscience-pharma
Genfit-company-profile
Free-report
Given-genfit
Urea-cycle-disorder
Organic-acidemia-disorder
Genfit-daily
Genfit
Otcmkts-gnftf
Gnftf
Medical

vimarsana © 2020. All Rights Reserved.